Authors
Loading...
Comparative imaging study reveals sestamibi SPECT underestimates myocardial viability compared with PET in coronary artery disease, suggesting PET utility for inferior wall assessment.
Soufer et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: